Comparing biological therapies in psoriasis: implications for clinical practice-Reference-Cited by-同舟云学术

Comparing biological therapies in psoriasis: implications for clinical practice

Published:2010-09-09 Issue: Volume:24 Page:10-14
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:

Author:

Griffiths CEM

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-3083.2010.03831.x/fullpdf

Reference35 articles.

1. British Association of Dermatologists Psoriasis - General Management http://www.bad.org.uk/site/769/Default.aspx

2. European S3-guidelines on the systemic treatment of psoriasis vulgaris;Pathirana;J Eur Acad Dermatol Venereol,2009

3. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis;Saurat;Dermatologica,1988

4. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris;Torras;J Dermatolog Treat,2004

5. [Photochemotherapy by 8-methoxypsoralen and UVA in psoriasis vulgaris--clinical experiences in 5 dermatological departments of GDR (author’s transl)];Barth;Dermatol Monatsschr,1978

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models;Cells;2019-09-15

2. Efficacy of several biological therapies for treating moderate to severe psoriasis: A network meta‑analysis;Experimental and Therapeutic Medicine;2018-10-15

3. Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways;Current Pharmaceutical Biotechnology;2018-03-12

4. Psoriatic arthritis: tissue-directed inflammation?;Clinical Rheumatology;2018-02-23

5. Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis;Circulation: Cardiovascular Imaging;2017-09